Supported by an advanced transit system, we have become capable of delivering the orders within promised time. Keeping the globally accepted packaging norms in consideration, we make certain that the packaging is done under the strict supervision of experts and professionals.
Ledifos is a combination of 2 hepatitis C virus (HCV) antiviral agents. It reduces the amount of HCV in the body by preventing the spread of the HCV within the body.
FDA-approved for the treatment of chronic hepatitis C genotype 1 in both treatment-naive and treatment-experienced patients.
The treatment duration depends on prior treatment experience and the presence or absence of cirrhosis.
Treatment experience is defined as patients who have failed treatment with either peginterferon plus ribavirin or peginterferon plus ribavirin plus a HCV protease inhibitor.